JP7400266B2 - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- JP7400266B2 JP7400266B2 JP2019154241A JP2019154241A JP7400266B2 JP 7400266 B2 JP7400266 B2 JP 7400266B2 JP 2019154241 A JP2019154241 A JP 2019154241A JP 2019154241 A JP2019154241 A JP 2019154241A JP 7400266 B2 JP7400266 B2 JP 7400266B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- dentinal tubule
- sealing effect
- aluminum
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 55
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 43
- -1 aluminum ions Chemical class 0.000 claims description 36
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 24
- 229910052782 aluminium Inorganic materials 0.000 claims description 19
- 239000000377 silicon dioxide Substances 0.000 claims description 19
- 239000000551 dentifrice Substances 0.000 claims description 15
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 13
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 12
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 claims description 12
- 229920006317 cationic polymer Polymers 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 239000001506 calcium phosphate Substances 0.000 claims description 9
- 229920002678 cellulose Polymers 0.000 claims description 9
- 239000001913 cellulose Substances 0.000 claims description 9
- 229920002907 Guar gum Polymers 0.000 claims description 8
- 206010020751 Hypersensitivity Diseases 0.000 claims description 8
- 208000026935 allergic disease Diseases 0.000 claims description 8
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 8
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 8
- 235000011010 calcium phosphates Nutrition 0.000 claims description 8
- 239000000665 guar gum Substances 0.000 claims description 8
- 235000010417 guar gum Nutrition 0.000 claims description 8
- 229960002154 guar gum Drugs 0.000 claims description 8
- 230000009610 hypersensitivity Effects 0.000 claims description 8
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 8
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims description 7
- 150000002222 fluorine compounds Chemical class 0.000 claims description 7
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims description 7
- 210000000214 mouth Anatomy 0.000 claims description 4
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims description 3
- 230000000694 effects Effects 0.000 description 92
- 210000005239 tubule Anatomy 0.000 description 60
- 238000007789 sealing Methods 0.000 description 54
- 239000000047 product Substances 0.000 description 25
- 238000003860 storage Methods 0.000 description 20
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 14
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 14
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 14
- 238000002156 mixing Methods 0.000 description 12
- 239000003082 abrasive agent Substances 0.000 description 10
- 235000019658 bitter taste Nutrition 0.000 description 10
- 125000002091 cationic group Chemical group 0.000 description 10
- 239000003205 fragrance Substances 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- 239000011230 binding agent Substances 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 235000019606 astringent taste Nutrition 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 235000019656 metallic taste Nutrition 0.000 description 8
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 7
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- 208000025371 Taste disease Diseases 0.000 description 5
- 210000004268 dentin Anatomy 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 4
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 239000011775 sodium fluoride Substances 0.000 description 4
- 235000013024 sodium fluoride Nutrition 0.000 description 4
- 239000000120 Artificial Saliva Substances 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 210000004517 glycocalyx Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- CFAKWWQIUFSQFU-UHFFFAOYSA-N 2-hydroxy-3-methylcyclopent-2-en-1-one Chemical compound CC1=C(O)C(=O)CC1 CFAKWWQIUFSQFU-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 201000002170 dentin sensitivity Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000008369 fruit flavor Substances 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 150000003016 phosphoric acids Chemical class 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- IAEGWXHKWJGQAZ-UHFFFAOYSA-N trimethylpyrazine Chemical compound CC1=CN=C(C)C(C)=N1 IAEGWXHKWJGQAZ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- JHEPBQHNVNUAFL-AATRIKPKSA-N (e)-hex-1-en-1-ol Chemical compound CCCC\C=C\O JHEPBQHNVNUAFL-AATRIKPKSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- MVOSYKNQRRHGKX-UHFFFAOYSA-N 11-Undecanolactone Chemical compound O=C1CCCCCCCCCCO1 MVOSYKNQRRHGKX-UHFFFAOYSA-N 0.000 description 1
- 239000001837 2-hydroxy-3-methylcyclopent-2-en-1-one Substances 0.000 description 1
- MDVYIGJINBYKOM-UHFFFAOYSA-N 3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]-1,2-propanediol Chemical compound CC(C)C1CCC(C)CC1OCC(O)CO MDVYIGJINBYKOM-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- TWXUTZNBHUWMKJ-UHFFFAOYSA-N Allyl cyclohexylpropionate Chemical compound C=CCOC(=O)CCC1CCCCC1 TWXUTZNBHUWMKJ-UHFFFAOYSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- NZGWDASTMWDZIW-UHFFFAOYSA-N Pulegone Natural products CC1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- APTGPWJUOYMUCE-UHFFFAOYSA-N S-Ethyl thioacetate Chemical compound CCSC(C)=O APTGPWJUOYMUCE-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- MEYPRMGRFQCXHY-UHFFFAOYSA-N [Na].F[Si](F)(F)F Chemical compound [Na].F[Si](F)(F)F MEYPRMGRFQCXHY-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical class [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Chemical class 0.000 description 1
- 239000000783 alginic acid Chemical class 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 238000005234 chemical deposition Methods 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- FXNRKXSSLJKNGH-UHFFFAOYSA-L dipotassium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [K+].[K+].[O-]P([O-])(F)=O FXNRKXSSLJKNGH-UHFFFAOYSA-L 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940091249 fluoride supplement Drugs 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000010651 grapefruit oil Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- 229920003063 hydroxymethyl cellulose Chemical class 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000002905 metal composite material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Chemical class 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Chemical class 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229960001245 olaflur Drugs 0.000 description 1
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 229930007459 p-menth-8-en-3-one Natural products 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- WBZFMJOAUABCPY-UHFFFAOYSA-N phenyl oxirane-2-carboxylate Chemical compound C1OC1C(=O)OC1=CC=CC=C1 WBZFMJOAUABCPY-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940068984 polyvinyl alcohol Drugs 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000011182 sodium carbonates Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- CAVXVRQDZKMZDB-UHFFFAOYSA-M sodium;2-[dodecanoyl(methyl)amino]ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CCS([O-])(=O)=O CAVXVRQDZKMZDB-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、水溶性アルミニウム化合物による象牙細管封鎖効果が向上し、即効的かつ保存後も安定に優れた象牙細管封鎖効果を与える、知覚過敏の抑制又は予防に好適な口腔用組成物に関する。 The present invention relates to an oral composition suitable for suppressing or preventing hypersensitivity, which improves the dentinal tubule-sealing effect of a water-soluble aluminum compound, provides an immediate and excellent dentinal tubule-sealing effect that is stable even after storage.
象牙質知覚過敏症とは、歯のエナメル質又はセメント質が消失して象牙質が露出し、この象牙質に温度的、化学的、機械的などの外来刺激が与えられることによって、一過性の非常に不快な痛みを生じるものである。この原因は、象牙細管を通じて神経が刺激されるためと考えられている。この知覚過敏症の痛みを緩和、除去し、あるいは予防するには、象牙細管の開口部を封鎖、狭窄することによって刺激の伝達を抑制、阻止することが有効である。歯磨剤等の口腔用組成物の口腔衛生製品による予防策としては、象牙細管を封鎖させたり、神経を鈍麻させるといった方法がなされている。 Dentin hypersensitivity is a temporary condition that occurs when the enamel or cementum of the tooth disappears and the dentin is exposed, and this dentin is exposed to external stimuli such as temperature, chemical, mechanical, etc. It causes very unpleasant pain. The reason for this is thought to be that nerves are stimulated through the dentinal tubules. In order to alleviate, eliminate, or prevent the pain caused by hypersensitivity, it is effective to suppress or prevent the transmission of stimuli by blocking or narrowing the openings of the dentinal tubules. As preventive measures using oral hygiene products such as oral compositions such as dentifrices, methods such as blocking dentinal tubules and dulling nerves have been used.
乳酸アルミニウム等の水溶性アルミニウム化合物は、歯磨剤組成物等の口腔用組成物に配合すると、アルミニウムイオンの象牙細管封鎖作用によって知覚過敏症の抑制又は予防効果を発揮し、口腔内での使用回数を増す度に象牙細管封鎖効果が高まるが、使用回数が少ない場合の効果は未だ十分とはいえず、効果の即効性の点で改善が求められていた。また、水溶性アルミニウム化合物を配合した口腔用組成物は、保存後に象牙細管封鎖効果が低下することがあり、効果の保存安定性の面でも改善の余地があった。 When water-soluble aluminum compounds such as aluminum lactate are added to oral compositions such as dentifrice compositions, they exhibit the effect of suppressing or preventing hypersensitivity due to the dentinal tubule-sealing action of aluminum ions, and the number of times they are used in the oral cavity increases. The effect of sealing dentinal tubules increases each time the amount is increased, but the effect is still not sufficient when the number of times of use is small, and there has been a need for improvement in terms of immediate effect. In addition, oral compositions containing water-soluble aluminum compounds sometimes have a reduced dentinal tubule sealing effect after storage, and there is still room for improvement in terms of storage stability.
口腔用組成物に水溶性アルミニウム化合物を配合して象牙細管封鎖効果を付与する技術が特許文献1~7に提案されている。
特許文献1(特許第6206153号公報)は、モノフルオロリン酸ナトリウム及びリン酸二水素ナトリウムの併用系によって、歯磨剤組成物での乳酸アルミニウムの象牙細管封鎖効果が保存後も安定に維持されること、特許文献2(特公平06-29171号公報)では、可溶性アルミニウム化合物含有口腔用組成物にヒドロキシアルキルセルロース及びカラゲナン、更には研磨剤として水酸化アルミニウムを配合すると、可溶性アルミニウム化合物が安定に配合されること、特許文献3、4(特許第2550909号公報、特公平07-042219号公報)では、乳酸アルミニウム等の水溶性アルミニウム化合物が象牙細管狭窄閉鎖に有効であること、その効果が特定の水溶性リン酸化合物等によって改善することを提案している。特許文献5(特許第5790455号公報)では、乳酸アルミニウム含有歯磨剤組成物にキサンタンガム等の特定水溶性高分子、アルギン酸プロピレングリコール及びシリカ系研磨剤を配合することで泡立ちを確保し、4週間(1日2回)使用後に知覚過敏予防効果が得られている。特許文献6(特許第6375350号公報)は、ラクタム化合物による乳酸アルミニウムの象牙細管封鎖効果の改善、特許文献7(特許第3152467号公報)は、水溶性アルミニウム化合物及びフッ素化合物を特定比率で用いた象牙質知覚過敏抑制作用の増強を提案している。しかし、これらの特許文献には、象牙細管封鎖効果の即効性に関して言及されていない。
Patent Documents 1 to 7 propose techniques for imparting a dentinal tubule sealing effect by blending a water-soluble aluminum compound into an oral composition.
Patent Document 1 (Patent No. 6206153) discloses that the dentinal tubule sealing effect of aluminum lactate in a dentifrice composition is stably maintained even after storage by a combination system of sodium monofluorophosphate and sodium dihydrogen phosphate. In particular, Patent Document 2 (Japanese Patent Publication No. 06-29171) discloses that when hydroxyalkyl cellulose and carrageenan, and further aluminum hydroxide as an abrasive are added to an oral composition containing a soluble aluminum compound, the soluble aluminum compound is stably mixed. In Patent Documents 3 and 4 (Japanese Patent No. 2550909, Japanese Patent Publication No. 07-042219), it is shown that water-soluble aluminum compounds such as aluminum lactate are effective in closing dentinal tubule strictures, and that the effect is effective in specific cases. It is proposed to improve the condition using water-soluble phosphoric acid compounds. In Patent Document 5 (Japanese Patent No. 5790455), foaming is ensured by blending a specific water-soluble polymer such as xanthan gum, propylene glycol alginate, and a silica-based abrasive into an aluminum lactate-containing dentifrice composition. After use (twice a day), the effect of preventing hypersensitivity has been obtained. Patent Document 6 (Patent No. 6375350) improves the dentinal tubule sealing effect of aluminum lactate using a lactam compound, and Patent Document 7 (Patent No. 3152467) uses a water-soluble aluminum compound and a fluorine compound in a specific ratio. It is proposed to enhance the effect of suppressing dentin hypersensitivity. However, these patent documents do not mention the immediate effect of the dentinal tubule sealing effect.
本発明は、上記事情に鑑みなされたもので、水溶性アルミニウム化合物による象牙細管封鎖効果を向上し、即効的かつ保存後も安定に優れた象牙細管封鎖効果を与える口腔用組成物を提供することを目的とする。 The present invention was made in view of the above circumstances, and an object of the present invention is to provide an oral composition that improves the dentinal tubule sealing effect of a water-soluble aluminum compound and provides an immediate and excellent dentinal tubule sealing effect that is stable even after storage. With the goal.
本発明者らは、上記目的を達成するため鋭意検討を行った結果、象牙細管封鎖効果の付与を目的に(A)水溶性アルミニウム塩を特定量以上配合し、かつ研磨剤として(C)シリカ等の特定物質を配合した口腔用組成物に(B)カチオン性高分子化合物を配合すると、(A)成分による象牙細管封鎖効果が向上して即効的かつ保存後も安定に優れた象牙細管封鎖効果が発揮され、上記課題を解決できることを見出した。 As a result of intensive studies to achieve the above object, the present inventors have found that (A) water-soluble aluminum salt is blended in a specific amount or more for the purpose of imparting a dentinal tubule-sealing effect, and (C) silica is used as an abrasive. When (B) a cationic polymer compound is blended into an oral composition containing specific substances such as, the dentinal tubule sealing effect of component (A) is improved, resulting in immediate and excellent dentinal tubule sealing that is stable even after storage. It has been found that the above-mentioned problems can be solved.
更に詳述すると、口腔用組成物において、乳酸アルミニウム等の水溶性アルミニウム化合物による象牙細管封鎖効果を発揮させて知覚過敏症を予防又は抑制するためには、遊離アルミニウムイオンとなって存在することが重要である。一方、水溶性アルミニウム化合物の添加量を増やしても効果の即効性は改善せず、保存後に効果低下も認められたが、これは、遊離アルミニウムイオンが配合成分中の研磨剤に吸着することが原因の一つとなっていることが明らかになった。そこで、この点に着目し、効果改善を目的として、本発明者らが更に検討を進めた結果、(A)水溶性アルミニウム塩に、研磨剤として(C)シリカ、炭酸カルシウム及びリン酸カルシウムから選ばれる1種以上を併用して配合し、更に(B)カチオン性高分子化合物を組み合わせて配合すると、他の研磨剤種に比べて(C)成分にはアルミニウムイオンが吸着され易いものであったが、意外にも、(B)成分によって、(A)成分のアルミニウムイオンが(C)成分に吸着されることなくその象牙細管封鎖作用が増強して素早く発現し、これにより、象牙細管封鎖効果の即効性が高まり、比較的使用回数が少なくても高い象牙細管封鎖効果を付与でき、しかも、その効果を保存後も安定に維持させることができ、また、味の良い使用感を与えることもできた。
本発明の作用効果は、(A)、(C)成分に(B)成分を組み合わせると、(A)成分が特定量以上において得られる、特異的な作用効果である。
後述の表3中の比較例に示すように、(B)成分が配合されていないと、セルロース誘導体のヒドロキシエチルセルロースが配合されていても、象牙細管封鎖効果(製造直後品の5サイクル後)が×で効果の即効性が劣り、象牙細管封鎖効果(保存後品の5サイクル後、20サイクル後)が共に×で保存後の効果の安定性も劣った(比較例3、4)。また、(A)成分量が少なすぎると、(B)成分が配合されていても、象牙細管封鎖効果(保存後品の5サイクル後、20サイクル後)が共に×で保存後に低下し、安定性が悪かった(比較例2)。
これに対して、後述の表1、2中の実施例に示すように、本発明の(A)、(B)及び(C)成分を含有し、(A)成分量が特定値以上である口腔用組成物は、象牙細管封鎖効果(製造直後品の5サイクル後、20サイクル後)及び象牙細管封鎖効果(保存後品の5サイクル後、20サイクル後)がいずれも高く、効果の即効性及び保存安定性に優れ、また、味(金属味、苦味、渋味のなさ)の良い使用感であった。
More specifically, in the oral composition, in order to prevent or suppress hypersensitivity by exerting the dentinal tubule sealing effect of a water-soluble aluminum compound such as aluminum lactate, it is necessary to exist in the form of free aluminum ions. is important. On the other hand, even if the amount of water-soluble aluminum compound added was increased, the immediate effect did not improve, and a decrease in the effect was observed after storage. It has become clear that this is one of the causes. Therefore, the present inventors focused on this point and conducted further studies with the aim of improving the effect. As a result, (A) a water-soluble aluminum salt and (C) a polishing agent selected from silica, calcium carbonate, and calcium phosphate were used. When one or more types of abrasives were combined together and further combined with (B) a cationic polymer compound, aluminum ions were more likely to be adsorbed to component (C) compared to other types of abrasives. Surprisingly, due to component (B), the aluminum ion of component (A) is not adsorbed to component (C), and its dentinal tubule-sealing effect is enhanced and quickly developed, thereby increasing the dentinal tubule-sealing effect. It has an improved immediate effect, can provide a high dentinal tubule sealing effect even with a relatively small number of uses, can maintain the effect stably even after storage, and can also provide a pleasant feeling of use. Ta.
The effect of the present invention is a specific effect that is obtained when component (B) is combined with components (A) and (C) in a specific amount or more of component (A).
As shown in the comparative example in Table 3 below, if component (B) is not blended, even if the cellulose derivative hydroxyethylcellulose is blended, the dentinal tubule sealing effect (after 5 cycles of the product immediately after manufacture) is lower. The immediate effect was poor in the case of ×, and the dentinal tubule sealing effect (after 5 cycles and 20 cycles of the product after preservation) was both poor in the stability of the effect after preservation (Comparative Examples 3 and 4). In addition, if the amount of component (A) is too small, even if component (B) is blended, the dentinal tubule sealing effect (after 5 cycles and 20 cycles of the product after storage) will both decrease after storage with × and become stable. The properties were poor (Comparative Example 2).
On the other hand, as shown in Examples in Tables 1 and 2 below, it contains components (A), (B), and (C) of the present invention, and the amount of component (A) is at least a specific value. The oral composition has a high dentinal tubule sealing effect (after 5 cycles and 20 cycles for the product immediately after manufacture) and a high dentinal tubule sealing effect (after 5 cycles and 20 cycles for the stored product), and has an immediate effect. It had excellent storage stability, and had a good taste (no metallic taste, no bitterness, no astringency).
なお、特許文献8(特許第5440150号公報)は、乳酸アルミニウムを1.0質量%以下で配合し、フッ化ナトリウムを配合した口腔用組成物にカチオン化セルロースを配合し、歯面へのフッ化物沈着促進効果を改善した発明である。これに対して、本発明は、(A)及び(C)成分に(B)成分を組み合わせることによる、(A)成分量1.2質量%以上における象牙細管封鎖効果の即効性及び保存安定性の向上である。 In addition, Patent Document 8 (Japanese Patent No. 5440150) discloses that cationized cellulose is blended into an oral composition containing 1.0% by mass or less of aluminum lactate and sodium fluoride, and fluoride is applied to tooth surfaces. This invention improves the effect of promoting chemical deposition. In contrast, the present invention provides immediate effect and storage stability of the dentinal tubule sealing effect when the amount of the (A) component is 1.2% by mass or more by combining the (B) component with the (A) and (C) components. This is an improvement in
従って、本発明は、下記の口腔用組成物を提供する。
〔1〕
(A)水溶性アルミニウム塩、
(B)カチオン性高分子化合物
並びに
(C)シリカ、炭酸カルシウム及びリン酸カルシウムから選ばれる1種以上
を含有し、(A)成分の含有量がアルミニウムイオンとして0.13~0.70質量%であることを特徴とする口腔用組成物。
〔2〕
(A)水溶性アルミニウム塩が、乳酸アルミニウム、塩化アルミニウム及び硫酸アルミニウムカリウムから選ばれる1種以上である〔1〕に記載の口腔用組成物。
〔3〕
(B)カチオン性高分子化合物が、カチオン化セルロース及びカチオン化グアーガムから選ばれる1種以上である〔1〕又は〔2〕に記載の口腔用組成物。
〔4〕
(C)成分の含有量が30質量%以下である〔1〕~〔3〕のいずれかに記載の口腔用組成物。
〔5〕
(B)成分の含有量が0.04~1質量%、(C)成分の含有量が3~30質量%である〔1〕~〔4〕のいずれかに記載の口腔用組成物。
〔6〕
更に、(D)水溶性フッ素化合物を含有する〔1〕~〔5〕のいずれかに記載の口腔用組成物。
〔7〕
(D)水溶性フッ素化合物が、モノフルオロリン酸ナトリウムであり、その含有量が0.1~5質量%である〔6〕に記載の口腔用組成物。
〔8〕
歯磨剤組成物である〔1〕~〔7〕のいずれかに記載の口腔用組成物。
〔9〕
知覚過敏抑制又は予防用である〔1〕~〔8〕のいずれかに記載の口腔用組成物。
Therefore, the present invention provides the following oral composition.
[1]
(A) water-soluble aluminum salt,
(B) Contains a cationic polymer compound and (C) one or more selected from silica, calcium carbonate, and calcium phosphate, and the content of component (A) is 0.13 to 0.70% by mass as aluminum ions. An oral composition characterized by:
[2]
(A) The oral composition according to [1], wherein the water-soluble aluminum salt is one or more selected from aluminum lactate, aluminum chloride, and potassium aluminum sulfate.
[3]
(B) The oral composition according to [1] or [2], wherein the cationic polymer compound is one or more selected from cationized cellulose and cationized guar gum.
[4]
The oral composition according to any one of [1] to [3] , wherein the content of component (C) is 30% by mass or less .
[5]
The oral composition according to any one of [1] to [4], wherein the content of component (B) is 0.04 to 1% by mass, and the content of component (C) is 3 to 30% by mass.
[6]
The oral composition according to any one of [1] to [5], further comprising (D) a water-soluble fluorine compound.
[7]
(D) The oral composition according to [6], wherein the water-soluble fluorine compound is sodium monofluorophosphate, and the content thereof is 0.1 to 5% by mass.
[8]
The oral cavity composition according to any one of [1] to [7], which is a dentifrice composition.
[9]
The oral composition according to any one of [1] to [8], which is used for suppressing or preventing hypersensitivity.
本発明によれば、水溶性アルミニウム化合物による象牙細管封鎖効果が向上し、即効的かつ保存後も安定に優れた象牙細管封鎖効果を与え、味も良く、知覚過敏症の抑制又は予防用として好適な口腔用組成物を提供できる。 According to the present invention, the water-soluble aluminum compound improves the dentinal tubule sealing effect, provides an immediate and excellent dentinal tubule sealing effect that is stable even after storage, has good taste, and is suitable for suppressing or preventing hypersensitivity. It is possible to provide a composition for oral cavity.
以下、本発明につき更に詳述する。本発明の口腔用組成物は、(A)水溶性アルミニウム塩、(B)カチオン性高分子化合物、及び(C)シリカ、炭酸カルシウム及びリン酸カルシウムから選ばれる1種以上を含有する。 The present invention will be explained in more detail below. The oral composition of the present invention contains (A) a water-soluble aluminum salt, (B) a cationic polymer compound, and (C) one or more selected from silica, calcium carbonate, and calcium phosphate.
(A)水溶性アルミニウム塩は、象牙細管封鎖効果を発揮する成分である。
水溶性アルミニウム塩は、象牙細管封鎖作用を有するものであればよく、例えば乳酸アルミニウム、塩化アルミニウム、硫酸アルミニウムカリウム等が挙げられ、これらの1種又は2種以上を使用できる。中でも乳酸アルミニウム、塩化アルミニウムが好ましく、より好ましくは乳酸アルミニウムである。これらは市販品を使用できる。
(A) Water-soluble aluminum salt is a component that exhibits a dentinal tubule sealing effect.
The water-soluble aluminum salt may be any salt as long as it has a dentinal tubule sealing effect, and examples thereof include aluminum lactate, aluminum chloride, potassium aluminum sulfate, etc., and one or more of these can be used. Among them, aluminum lactate and aluminum chloride are preferred, and aluminum lactate is more preferred. Commercially available products can be used for these.
(A)成分の配合量は、象牙細管封鎖効果及び味の点から、アルミニウムイオン量として、組成物全体の0.1%(質量%、以下同様)以上であり、特に0.10~1%が好ましく、より好ましくは0.11~0.95%、更に好ましくは0.13~0.70%である。アルミニウムイオン量が0.1%未満であると、象牙細管封鎖効果、特にその安定性が劣る。配合量が増えるにつれて象牙細管封鎖効果が高まるが、多く配合しすぎるとそれ自身の金属味が発現し味に影響する場合があり、1%以下であると、味の良さを十分に保つことができる。
更に、水溶性アルミニウム塩の配合量は、組成物全体の1.2%以上が好ましく、より好ましくは1.2~11%、更に好ましくは1.2~10%、最も好ましくは1.5~7%である。
From the viewpoint of dentinal tubule sealing effect and taste, the blending amount of component (A) is 0.1% (mass%, the same shall apply hereinafter) of the entire composition as the amount of aluminum ions, particularly 0.10 to 1%. is preferable, more preferably 0.11 to 0.95%, still more preferably 0.13 to 0.70%. If the amount of aluminum ions is less than 0.1%, the dentinal tubule sealing effect, especially its stability, will be poor. The effect of sealing dentinal tubules increases as the amount added increases, but if too much is added, it may develop its own metallic taste and affect the taste, and if it is less than 1%, the good taste cannot be maintained sufficiently. can.
Furthermore, the amount of water-soluble aluminum salt blended is preferably 1.2% or more of the entire composition, more preferably 1.2 to 11%, still more preferably 1.2 to 10%, and most preferably 1.5 to 10%. It is 7%.
(B)カチオン性高分子化合物は、(A)成分の象牙細管封鎖効果を高め、特に、効果の即効性を向上し、かつ保存後も持続的に象牙細管封鎖効果を安定に保つ作用を奏する。
(B)カチオン性高分子化合物は、例えばカチオン化セルロース、ジメチルジアリルアンモニウムのホモポリマー、塩化ジメチルジアリルアンモニウムとエチレン性不飽和炭化水素基を有する重合可能な単量体とのコポリマー、カチオン化ポリビニルピロリドン、カチオン化ポリアミド、カチオン化ポリメタクリレート、カチオン化ポリアクリルアミド、カチオン化メタクリレートとアクリルアミドとのコポリマー、カチオン化メタクリレートとメタクリレートのコポリマー、ポリエチレンイミド、カチオン化デンプン、カチオン化アミロース、カチオン化グアーガム、カチオン化ローストビーンガム、カチオン化寒天、キチン、キトサン及びこれらの変性物等が挙げられ、窒素含有量が0.1~3%であるものが好ましい。これらは、1種単独で又は2種以上を組み合わせて使用できる。中でも、カチオン化セルロース、カチオン化グアーガムが好ましく、より好ましくはカチオン化セルロースである。
(B) The cationic polymer compound enhances the dentinal tubule-sealing effect of component (A), particularly improves the immediate effect, and maintains the dentinal tubule-sealing effect stably even after storage. .
(B) The cationic polymer compound is, for example, a cationized cellulose, a homopolymer of dimethyldiallylammonium, a copolymer of dimethyldiallylammonium chloride and a polymerizable monomer having an ethylenically unsaturated hydrocarbon group, or a cationized polyvinylpyrrolidone. , cationic polyamide, cationic polymethacrylate, cationic polyacrylamide, copolymer of cationic methacrylate and acrylamide, copolymer of cationic methacrylate and methacrylate, polyethyleneimide, cationic starch, cationic amylose, cationic guar gum, cationic roast Examples include bean gum, cationized agar, chitin, chitosan, and modified products thereof, and those having a nitrogen content of 0.1 to 3% are preferred. These can be used alone or in combination of two or more. Among these, cationized cellulose and cationized guar gum are preferred, and cationized cellulose is more preferred.
カチオン化セルロースは、例えばヒドロキシエチルセルロースにジメチルジアリルアンモニウム塩をグラフト重合した、ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド等のヒドロキシエチルセルロースジメチルジアリルアンモニウム塩、ヒドロキシエチルセルロースに2,3-エポキシプロピルトリメチルアンモニウムクロリドを結合した塩化O-〔2-ヒドロキシ-3-(トリメチルアンモニオ)プロピル〕ヒドロキシエチルセルロース等が挙げられる。中でも、ヒドロキシエチルセルロースジメチルジアリルアンモニウム塩、塩化O-〔2-ヒドロキシ-3-(トリメチルアンモニオ)プロピル〕ヒドロキシエチルセルロース、特にヒドロキシエチルセルロースジメチルジアリルアンモニウム塩が好ましい。
カチオン化グアーガムは、例えば塩化O-〔2-ヒドロキシ-3-(トリメチルアンモニオ)プロピル〕グアーガム等が挙げられる。
Cationized cellulose includes, for example, hydroxyethylcellulose dimethyldiallylammonium salt such as hydroxyethylcellulose dimethyldiallylammonium chloride, which is obtained by graft polymerizing dimethyldiallylammonium salt onto hydroxyethylcellulose, and O chloride which is obtained by bonding 2,3-epoxypropyltrimethylammonium chloride to hydroxyethylcellulose. -[2-hydroxy-3-(trimethylammonio)propyl]hydroxyethylcellulose and the like. Among these, hydroxyethylcellulose dimethyldiallylammonium salt, O-[2-hydroxy-3-(trimethylammonio)propyl]hydroxyethylcellulose chloride, and especially hydroxyethylcellulose dimethyldiallylammonium salt are preferred.
Examples of the cationized guar gum include chlorinated O-[2-hydroxy-3-(trimethylammonio)propyl]guar gum.
(B)カチオン性高分子化合物は、市販品を使用できる。具体的にヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリドは、アクゾノーベル(株)製のセルコートL-200、セルコートH-100等、塩化O-〔2-ヒドロキシ-3-(トリメチルアンモニオ)プロピル〕ヒドロキシエチルセルロースは、ライオン(株)製のレオガードMGP等が挙げられる。塩化O-〔2-ヒドロキシ-3-(トリメチルアンモニオ)プロピル〕グアーガムは、三晶(株)製のジャガーC-17等が挙げられる。 (B) A commercially available product can be used as the cationic polymer compound. Specifically, hydroxyethylcellulose dimethyldiallylammonium chloride is manufactured by Akzo Nobel Co., Ltd., such as Cellcoat L-200 and Cellcoat H-100, and O-[2-hydroxy-3-(trimethylammonio)propyl]hydroxyethylcellulose chloride is Examples include Leoguard MGP manufactured by Lion Corporation. Examples of O-[2-hydroxy-3-(trimethylammonio)propyl]guar gum chloride include Jaguar C-17 manufactured by Sansho Co., Ltd.
(B)カチオン性高分子化合物の配合量は、組成物全体の0.04~1%が好ましく、より好ましくは0.05~0.7%、更に好ましくは0.3~0.7%である。配合量が0.04%以上であると、象牙細管封鎖効果の即効性及び安定性が十分に向上する。配合量が増えるほど象牙細管封鎖効果の即効性が高まり、効果が保存後もより安定に維持されるが、多く配合し過ぎるとそれ自身の苦味が生じる場合があり、1%以下であると十分に苦味を抑え良い味を保持できる。 (B) The blending amount of the cationic polymer compound is preferably 0.04 to 1%, more preferably 0.05 to 0.7%, and even more preferably 0.3 to 0.7% of the total composition. be. When the blending amount is 0.04% or more, the immediate effect and stability of the dentinal tubule sealing effect are sufficiently improved. As the amount added increases, the immediate effect of the dentinal tubule sealing effect increases, and the effect is maintained more stably even after storage, but if too much is added, it may produce its own bitter taste, so 1% or less is sufficient. It suppresses bitterness and retains good taste.
(C)成分は、シリカ、炭酸カルシウム及びリン酸カルシウムから選ばれる1種又は2種以上であり、これらは研磨剤である。
シリカとしては、シリカ(無水ケイ酸)を含む研磨剤、例えばシリカゲル、沈降性シリカ、ジルコノシリケート、アルミノシリケート等のシリカ系研磨剤が挙げられ、シリカを含んでいればアルミニウム、ジルコニウム等の金属を更に含む金属複合シリカでもよく、これらを使用し得る。本発明にかかわる(C)成分において、「シリカ」とは、上記のシリカ(無水ケイ酸)を含む研磨剤を意味する。
炭酸カルシウムとしては、軽質炭酸カルシウム、重質炭酸カルシウム等の炭酸カルシウム系研磨剤が挙げられ、これらを使用し得る。
リン酸カルシウムとしては、第二リン酸カルシウム2水和物、第二リン酸カルシウム無水和物、ピロリン酸カルシウム等のリン酸カルシウム系研磨剤が挙げられ、これらを使用し得る。
これらは、1種単独で又は2種以上を組み合わせて使用できる。これらは市販品を用いることができる。
(C)成分としては、特に、象牙細管封鎖効果の即効性の点から、シリカ系研磨剤、炭酸カルシウム系研磨剤が好ましく、象牙細管封鎖効果の即効性と繰り返し使用後の象牙細管封鎖効果の点から、とりわけシリカ系研磨剤が好ましい。
Component (C) is one or more selected from silica, calcium carbonate, and calcium phosphate, and these are abrasives.
Examples of silica include abrasives containing silica (silicic anhydride), such as silica-based abrasives such as silica gel, precipitated silica, zirconosilicate, and aluminosilicate, and metals such as aluminum and zirconium that contain silica. Metal composite silica further containing these may be used. In the component (C) according to the present invention, "silica" means an abrasive containing the above-mentioned silica (silicic anhydride).
Examples of calcium carbonate include calcium carbonate-based abrasives such as light calcium carbonate and heavy calcium carbonate, and these can be used.
Examples of calcium phosphate include calcium phosphate-based abrasives such as dicalcium phosphate dihydrate, dicalcium phosphate anhydrate, and calcium pyrophosphate, which may be used.
These can be used alone or in combination of two or more. Commercially available products can be used for these.
As component (C), silica-based abrasives and calcium carbonate-based abrasives are particularly preferred from the viewpoint of immediate dentinal tubule sealing effect, and the immediate effect of dentinal tubule sealing effect and the improvement of dentinal tubule sealing effect after repeated use. From this point of view, silica-based abrasives are particularly preferred.
(C)成分の配合量は、組成物全体の30%以下が好ましく、より好ましくは25%以下、更に好ましくは15%以下である。下限量は特に設定されないが、清掃実感の点から、3%以上が好ましく、より好ましくは5%以上である。多く配合しすぎると、象牙細管封鎖効果、特に保存後に効果の即効性が低下する場合があり、配合量が30%以下であると、象牙細管封鎖効果の即効性及び安定性が十分に優れる。 The blending amount of component (C) is preferably 30% or less of the entire composition, more preferably 25% or less, and still more preferably 15% or less. The lower limit is not particularly set, but from the point of view of cleaning experience, it is preferably 3% or more, more preferably 5% or more. If too much is added, the immediate effect of the dentinal tubule sealing effect, especially after storage, may be reduced. If the amount is 30% or less, the immediate effect and stability of the dentinal tubule sealing effect are sufficiently excellent.
本発明では、更に(D)水溶性フッ素化合物を配合することが好ましい。(B)成分と共に(D)成分を併用して配合すると、(D)成分が、(B)成分による象牙細管封鎖効果の改善効果を高めて効果の即効性及び安定性、とりわけ保存後の象牙細管封鎖効果の即効性を更に向上する作用を奏する。
水溶性フッ素化合物は、例えばモノフルオロリン酸ナトリウム、フッ化ナトリウム、フッ化カリウム、フッ化アンモニウム、フッ化スズ、アミンフッ化物、モノフルオロリン酸カリウム、フッ化ケイ素ナトリウム等が挙げられるが、好ましくはモノフルオロリン酸ナトリウム、フッ化ナトリウムであり、特にモノフルオロリン酸ナトリウムが好ましい。
In the present invention, it is preferable to further include (D) a water-soluble fluorine compound. When component (D) is combined with component (B), component (D) enhances the effect of improving the dentinal tubule sealing effect of component (B), improving the immediate effect and stability of the effect, especially on dentinal dentin after storage. It has the effect of further improving the immediate effect of the capillary sealing effect.
Examples of water-soluble fluorine compounds include sodium monofluorophosphate, sodium fluoride, potassium fluoride, ammonium fluoride, tin fluoride, amine fluoride, potassium monofluorophosphate, and sodium silicon fluoride, but preferably These include sodium monofluorophosphate and sodium fluoride, with sodium monofluorophosphate being particularly preferred.
(D)成分の配合量は使用物質に応じて調整され、(D)成分としてモノフルオロリン酸ナトリウムを配合する場合、その配合量は、組成物全体の0.1~5%が好ましく、より好ましくは0.5~3%であり、更に好ましくは1~2%である。
また、(D)成分としてフッ化ナトリウムを配合する場合、その配合量は、組成物全体の0.05~3%が好ましく、より好ましくは0.1~1%である。
(D)成分の配合量が上記範囲内であると、象牙細管封鎖効果が十分に底上げされて高まり、また、渋味、苦味が十分に抑えられ味の良い使用感を保持できる。
The blending amount of component (D) is adjusted depending on the substance used. When sodium monofluorophosphate is blended as component (D), the blending amount is preferably 0.1 to 5% of the entire composition, and more It is preferably 0.5 to 3%, more preferably 1 to 2%.
Furthermore, when sodium fluoride is blended as component (D), the blending amount is preferably 0.05 to 3%, more preferably 0.1 to 1% of the total composition.
When the amount of component (D) is within the above range, the dentinal tubule sealing effect is sufficiently enhanced and the astringency and bitterness are sufficiently suppressed to maintain a pleasant feeling of use.
本発明の口腔用組成物は、特に練歯磨等の歯磨剤組成物として好適である。また、上記成分に加えて、これら以外の公知成分を本発明の効果を妨げない範囲で必要に応じて配合できる。例えば、練歯磨剤では、界面活性剤、粘結剤、湿潤剤、甘味剤、防腐剤、着色剤、香料、pH調整剤、薬効成分等を配合することができる。なお、配合量は本発明の効果を妨げない範囲で通常量でよい。 The oral composition of the present invention is particularly suitable as a dentifrice composition such as toothpaste. Furthermore, in addition to the above-mentioned components, other known components may be blended as needed within a range that does not impede the effects of the present invention. For example, a toothpaste can contain surfactants, binders, wetting agents, sweeteners, preservatives, colorants, fragrances, pH adjusters, medicinal ingredients, and the like. Incidentally, the blending amount may be a normal amount within a range that does not impede the effects of the present invention.
界面活性剤は、アニオン性界面活性剤、ノニオン性界面活性剤、カチオン性界面活性剤、両性界面活性剤を配合できる。
アニオン性界面活性剤としては、ラウリル硫酸ナトリウム等のアルキル硫酸塩、ラウロイルメチルタウリンナトリウム等のアシルタウリン塩、アシルサルコシン酸塩、アシルアミノ酸塩が挙げられる。
ノニオン性界面活性剤としては、ショ糖脂肪酸エステル等の糖脂肪酸エステル、糖アルコール脂肪酸エステル、ソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油等のポリオキシエチレン脂肪酸エステル、ポリオキシエチレン高級アルコールエーテル、脂肪酸アルカノールアミドが挙げられる。
カチオン性界面活性剤としては、アルキルアンモニウム型、アルキルベンジルアンモニウム塩等、両性界面活性剤としては、ベタイン型、イミダゾリン型、イミダゾリウムベタイン型等が挙げられる。
界面活性剤の配合量は、通常、組成物全体の0.001~10%、特に0.1~5%である。
As the surfactant, anionic surfactants, nonionic surfactants, cationic surfactants, and amphoteric surfactants can be blended.
Examples of the anionic surfactant include alkyl sulfates such as sodium lauryl sulfate, acyl taurine salts such as sodium lauroylmethyltaurate, acyl sarcosinates, and acyl amino acid salts.
Examples of nonionic surfactants include sugar fatty acid esters such as sucrose fatty acid esters, sugar alcohol fatty acid esters, sorbitan fatty acid esters, glycerin fatty acid esters, polyglycerin fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene hydrogenated castor oil, etc. Examples include polyoxyethylene fatty acid ester, polyoxyethylene higher alcohol ether, and fatty acid alkanolamide.
Examples of cationic surfactants include alkyl ammonium types and alkylbenzylammonium salts, and examples of amphoteric surfactants include betaine types, imidazoline types, and imidazolium betaine types.
The amount of surfactant to be blended is usually 0.001 to 10%, particularly 0.1 to 5% of the total composition.
粘結剤は、(B)成分以外の有機粘結剤又は無機粘結剤を配合できる。具体的に有機粘結剤としては、セルロース誘導体であるカルボキシメチルセルロースナトリウム、メチルセルロース、ヒドロキシメチルセルロースや、アルギン酸誘導体、更には、キサンタンガム等のガム類、カラギーナン、ポリビニルアルコール、ポリアクリル酸ナトリウムが挙げられる。無機粘結剤としては、増粘性シリカ、増粘性アルミニウムシリカが挙げられる。これら粘結剤の配合量は、通常、組成物全体の0.1~10質量%、特に0.5~5%である。なお、本発明では、効果発現の点で、特に有機粘結剤が好ましく、有機粘結剤の配合量は、組成物全体の0.1~5%、特に0.5~3%がよい。 The binder may contain an organic binder or an inorganic binder other than component (B). Specific examples of the organic binder include cellulose derivatives such as sodium carboxymethylcellulose, methylcellulose, and hydroxymethylcellulose, alginic acid derivatives, gums such as xanthan gum, carrageenan, polyvinyl alcohol, and sodium polyacrylate. Examples of the inorganic binder include thickening silica and thickening aluminum silica. The blending amount of these binders is usually 0.1 to 10% by weight, particularly 0.5 to 5% by weight, based on the total composition. In the present invention, organic binders are particularly preferred in terms of effectiveness, and the amount of organic binders to be blended is preferably 0.1 to 5%, particularly 0.5 to 3%, based on the total composition.
湿潤剤は、ソルビット、キシリット等の糖アルコール、グリセリン、プロピレングリコール等の多価アルコールが挙げられる。湿潤剤の配合量は、通常、組成物全体の5~50%、特に20~45%である。 Examples of wetting agents include sugar alcohols such as sorbitol and xylit, and polyhydric alcohols such as glycerin and propylene glycol. The amount of wetting agent incorporated is usually 5 to 50%, particularly 20 to 45% of the total composition.
甘味剤は、サッカリンナトリウム等が挙げられる。
防腐剤は、パラオキシ安息香酸エステル、安息香酸又はその塩等が挙げられる。
着色剤は、青色1号、黄色4号、二酸化チタン等が挙げられる。
Examples of sweeteners include sodium saccharin.
Examples of the preservative include paraoxybenzoic acid ester, benzoic acid, or a salt thereof.
Examples of the coloring agent include Blue No. 1, Yellow No. 4, and titanium dioxide.
香料は、ペパーミント油、スペアミント油、アニス油、ユーカリ油、ウィンターグリーン油、カシア油、クローブ油、タイム油、セージ油、レモン油、オレンジ油、ハッカ油、カルダモン油、コリアンダー油、マンダリン油、ライム油、ラベンダー油、ローズマリー油、ローレル油、カモミル油、キャラウェイ油、マジョラム油、ベイ油、レモングラス油、オリガナム油、パインニードル油、ネロリ油、ローズ油、ジャスミン油、グレープフルーツ油、スウィーティー油、柚油、イリスコンクリート、アブソリュートペパーミント、アブソリュートローズ、オレンジフラワー等の天然香料や、これら天然香料の加工処理(前溜部カット、後溜部カット、分留、液液抽出、エッセンス化、粉末香料化等)した香料、及び、メントール、カルボン、アネトール、シネオール、サリチル酸メチル、シンナミックアルデヒド、オイゲノール、3-l-メントキシプロパン-1,2-ジオール、チモール、リナロール、リナリールアセテート、リモネン、メントン、メンチルアセテート、N-置換-パラメンタン-3-カルボキサミド、ピネン、オクチルアルデヒド、シトラール、プレゴン、カルビールアセテート、アニスアルデヒド、エチルアセテート、エチルブチレート、アリルシクロヘキサンプロピオネート、メチルアンスラニレート、エチルメチルフェニルグリシデート、バニリン、ウンデカラクトン、ヘキサナール、ブタノール、イソアミルアルコール、ヘキセノール、ジメチルサルファイド、シクロテン、フルフラール、トリメチルピラジン、エチルラクテート、エチルチオアセテート等の単品香料、更に、ストロベリーフレーバー、アップルフレーバー、バナナフレーバー、パイナップルフレーバー、グレープフレーバー、マンゴーフレーバー、バターフレーバー、ミルクフレーバー、フルーツミックスフレーバー、トロピカルフルーツフレーバー等の調合香料等、口腔用組成物に用いられる公知の香料素材を組み合わせて使用することができる。
香料の配合量は特に限定されないが、上記の香料素材は、組成物中に0.000001~1%使用するのが好ましく、上記香料素材を使用した賦香用香料は、組成物中に0.1~2%使用するのが好ましい。
Fragrances include peppermint oil, spearmint oil, anise oil, eucalyptus oil, wintergreen oil, cassia oil, clove oil, thyme oil, sage oil, lemon oil, orange oil, peppermint oil, cardamom oil, coriander oil, mandarin oil, lime. Oil, lavender oil, rosemary oil, laurel oil, chamomile oil, caraway oil, marjoram oil, bay oil, lemongrass oil, origanum oil, pine needle oil, neroli oil, rose oil, jasmine oil, grapefruit oil, sweetie oil Natural fragrances such as , yuzu oil, iris concrete, absolute peppermint, absolute rose, orange flower, etc., and processing of these natural fragrances (front distillation cut, rear distillation cut, fractional distillation, liquid-liquid extraction, essence formation, powder fragrance) menthol, carvone, anethole, cineole, methyl salicylate, cinnamic aldehyde, eugenol, 3-l-menthoxypropane-1,2-diol, thymol, linalool, linaryl acetate, limonene, menthone , menthyl acetate, N-substituted-paramenthane-3-carboxamide, pinene, octylaldehyde, citral, pulegone, carbyl acetate, anisaldehyde, ethyl acetate, ethyl butyrate, allylcyclohexane propionate, methyl anthranilate, ethyl methyl Individual fragrances such as phenylglycidate, vanillin, undecalactone, hexanal, butanol, isoamyl alcohol, hexenol, dimethyl sulfide, cyclotene, furfural, trimethylpyrazine, ethyl lactate, ethylthioacetate, as well as strawberry flavor, apple flavor, and banana flavor. , pineapple flavor, grape flavor, mango flavor, butter flavor, milk flavor, mixed fruit flavor, tropical fruit flavor, and other known flavor materials used in oral compositions can be used in combination.
Although the blending amount of the fragrance is not particularly limited, it is preferable that the above-mentioned fragrance material is used in the composition in an amount of 0.000001 to 1%, and the fragrance using the above-mentioned fragrance material is used in the composition in an amount of 0.000001 to 1%. It is preferred to use 1-2%.
pH調整剤を添加してもよく、例えば水酸化ナトリウム等のアルカリ金属の水酸化物、炭酸水素塩、炭酸塩などが挙げられる。 A pH adjuster may be added, and examples thereof include alkali metal hydroxides such as sodium hydroxide, hydrogen carbonates, carbonates, and the like.
薬効成分は、通常、有効成分として配合される公知のもの、例えばイソプロピルメチルフェノール等の非イオン性殺菌剤、塩化セチルピリジニウム等のカチオン性殺菌剤、トラネキサム酸、アラントイン等の抗炎症剤、デキストラナーゼ等の酵素、水溶性リン酸化合物、塩化ナトリウム、硝酸カリウム等の無機塩類、アスコルビン酸、酢酸トコフェロール等のビタミン類、植物抽出物、歯石防止剤、歯垢防止剤が挙げられる。薬効成分は、本発明の効果を妨げない範囲で有効量配合することができる。 The medicinal ingredients are generally known active ingredients, such as nonionic bactericidal agents such as isopropylmethylphenol, cationic bactericidal agents such as cetylpyridinium chloride, anti-inflammatory agents such as tranexamic acid and allantoin, and dextra. Examples include enzymes such as enzymes such as enzymes, water-soluble phosphoric acid compounds, inorganic salts such as sodium chloride and potassium nitrate, vitamins such as ascorbic acid and tocopherol acetate, plant extracts, anti-tartar agents, and anti-plaque agents. The medicinal ingredients can be blended in an effective amount within a range that does not interfere with the effects of the present invention.
以下、実施例及び比較例を示し、本発明を具体的に説明するが、本発明は下記の実施例に制限されるものではない。なお、下記の例において%は特に断らない限りいずれも質量%を示す。 EXAMPLES Hereinafter, the present invention will be specifically explained with reference to Examples and Comparative Examples, but the present invention is not limited to the Examples below. In addition, in the following examples, % indicates mass % unless otherwise specified.
[実施例、比較例]
表1~3に示す組成の歯磨剤組成物(練歯磨剤)を常法によって調製し、これらを試験歯磨剤として使用し、下記方法で評価した。結果を表1~3に併記した。
[Example, Comparative Example]
Dentifrice compositions (dentifrices) having the compositions shown in Tables 1 to 3 were prepared by conventional methods, used as test dentifrices, and evaluated by the following method. The results are also listed in Tables 1 to 3.
<象牙細管封鎖効果の評価方法>
1~2mmにカットしたヒト臼歯の象牙質部分を、ヤスリで片面のみ研磨し、歯の切片を37%リン酸水溶液に45秒間浸漬してエッチングした後、水で洗浄後、超音波洗浄を行った(0サイクル)。このヒト臼歯の象牙質部分を、試験歯磨剤上清液(試験歯磨剤を人工唾液で3倍に希釈し、10分間振とう機で撹拌後、10,000rpmで10分間遠心分離した上清液)に浸漬(人工唾液3倍希釈、3分間浸漬)し、洗浄後に、人工唾液に37℃下で10分間浸漬するという操作を5回繰り返して行った(5サイクル)。その後、レーザーマイクロスコープにて象牙細管を撮影した。更に、上記操作を繰り返し、合計20回行った後(20サイクル)、同様に象牙細管を撮影した。得られた画像を2色調化し、封鎖されていない象牙細管開口面積の割合を下記式によって求めた。
象牙細管開口面積の割合(%)=
(5又は20サイクル目の象牙細管開口面積/0サイクル目の象牙細管開口面積)×100
得られた象牙細管開口面積の割合から、下記の評価基準に基づき象牙細管封鎖効果を評価した。
評価基準
◎◎:象牙細管開口面積の割合が20%未満である
◎ :象牙細管開口面積の割合が20%以上30%未満である
〇 :象牙細管開口面積の割合が30%以上50%未満である
△ :象牙細管開口面積の割合が50%以上60%未満である
× :象牙細管開口面積の割合が60%以上である
なお、象牙細管封鎖効果の評価は、製造直後の歯磨剤組成物(製造直後品)、50℃、75%RH条件下で1ヶ月間保存した歯磨剤組成物(保存後品)を用い、それぞれについて、上記の操作5サイクル終了後と操作20サイクル終了後に行い、これらの結果を、象牙細管封鎖効果(製造直後品、5サイクル後又は20サイクル後)、象牙細管封鎖効果(保存後品、5サイクル後又は20サイクル後)として示した。
効果の即効性は、操作5サイクル終了後の評価結果から、また、効果の安定性は、製造直後品と保存後品の20サイクル終了後の評価結果を比べることで判断した。
<Evaluation method of dentinal tubule sealing effect>
The dentin part of a human molar tooth cut into 1-2 mm pieces was polished on one side with a file, and the tooth section was etched by immersing it in a 37% phosphoric acid aqueous solution for 45 seconds, followed by washing with water and ultrasonic cleaning. (0 cycles). The dentin part of this human molar was prepared by diluting the test dentifrice supernatant (the test dentifrice was diluted 3 times with artificial saliva, stirred with a shaker for 10 minutes, and then centrifuged at 10,000 rpm for 10 minutes. ) (3-fold dilution of artificial saliva, immersion for 3 minutes), and after washing, immersion in artificial saliva for 10 minutes at 37°C was repeated 5 times (5 cycles). Thereafter, the dentinal tubules were photographed using a laser microscope. Furthermore, after repeating the above operation 20 times in total (20 cycles), the dentinal tubules were photographed in the same manner. The obtained image was divided into two tones, and the ratio of the open area of the dentinal tubules that were not blocked was determined using the following formula.
Percentage of dentinal tubule opening area (%) =
(Dentinal tubule opening area at 5th or 20th cycle/dentinal tubule opening area at 0th cycle) x 100
From the ratio of the dentinal tubule opening area obtained, the dentinal tubule sealing effect was evaluated based on the following evaluation criteria.
Evaluation criteria ◎◎: The ratio of the dentinal tubule opening area is less than 20%. ◎: The ratio of the dentinal tubule opening area is 20% or more and less than 30%. ○: The ratio of the dentinal tubule opening area is 30% or more and less than 50%. Yes △: The ratio of the dentinal tubule opening area is 50% or more and less than 60%. ×: The ratio of the dentinal tubule opening area is 60% or more. Using dentifrice compositions (products immediately after manufacture) and dentifrice compositions stored for one month at 50°C and 75% RH conditions (post-preservation products), the test was carried out after the completion of 5 cycles of the above operations and after completion of 20 cycles of operations. The results were shown as dentinal tubule sealing effect (product immediately after manufacture, after 5 cycles or 20 cycles) and dentinal tubule sealing effect (product after storage, after 5 cycles or 20 cycles).
The immediate effect was determined from the evaluation results after 5 cycles of operation, and the stability of the effects was determined by comparing the evaluation results after 20 cycles of the product immediately after production and the product after storage.
<使用感の評価方法>
製造直後品のサンプルについて、被験者5人(専門パネラーn=5)による使用感評価を行った。歯ブラシ(クリニカアドバンテージハブラシ、4列コンパクトふつうタイプ)にサンプル1gをのせ、3分間歯みがきを行った。すすぎ直後に、味についてのアンケートを実施し、下記の評点基準に基づき味について判定した。5人の平均点を算出し、下記の評価基準を用いて味(金属味、苦味及び渋味のなさ)を評価した。
評点基準
1:金属味、苦味、渋味のいずれかを非常に感じる
2:金属味、苦味、渋味のいずれかをかなり感じる
3:金属味、苦味、渋味のいずれかをやや感じるが問題ないレベル
4:金属味、苦味、渋味をほとんど感じない
5:金属味、苦味、渋味を感じない
評価基準
◎:5人の平均点が3.5点以上である
○:5人の平均点が2.5点以上3.5点未満である
△:5人の平均点が2点以上2.5点未満である
×:5人の平均点が2点未満である
<How to evaluate usability>
Five test subjects (expert panelists n=5) evaluated the usability of the product samples immediately after manufacture. 1 g of the sample was placed on a toothbrush (Clinica Advantage toothbrush, 4-row compact normal type), and teeth were brushed for 3 minutes. Immediately after rinsing, a questionnaire regarding the taste was conducted, and the taste was judged based on the following rating criteria. The average score of the five people was calculated, and the taste (lack of metallic taste, bitterness, and astringency) was evaluated using the following evaluation criteria.
Scoring criteria 1: Very strong metallic, bitter, or astringent taste 2: Very metallic, bitter, or astringent taste 3: Somewhat metallic, bitter, or astringent taste, but problematic No level 4: Almost no metallic taste, bitterness, or astringency 5: No metallic taste, bitterness, or astringency Evaluation criteria ◎: Average score of 5 people is 3.5 points or higher ○: Average of 5 people The score is 2.5 points or more and less than 3.5 points. △: The average score of 5 people is 2 points or more and less than 2.5 points. ×: The average score of 5 people is less than 2 points.
なお、(B)、(C)成分としては下記を使用した。
(B)ヒドロキシエチルセルロースジメチルジアリルアンモニウム塩
ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド
アクゾノーベル(株)製、商品名;セルコートL-200
(B)塩化O-〔2-ヒドロキシ-3-(トリメチルアンモニオ)プロピル〕ヒドロキシエチルセルロース
ライオン(株)製、商品名;レオガードMGP
(B)塩化O-〔2-ヒドロキシ-3-(トリメチルアンモニオ)プロピル〕グアーガム
三晶(株)製、商品名;ジャガーC-17
(C)無水ケイ酸
多木化学(株)製、商品名;無水ケイ酸
(C)炭酸カルシウム
(株)カルファイン製、商品名;重質炭酸カルシウム
(C)リン酸カルシウム
東ソー・アクゾ(株)製、商品名;第二リン酸カルシウム・2水和物
The following components (B) and (C) were used.
(B) Hydroxyethylcellulose dimethyldiallylammonium salt Hydroxyethylcellulose dimethyldiallylammonium chloride Manufactured by Akzo Nobel Co., Ltd., product name: Cellcoat L-200
(B) O-[2-hydroxy-3-(trimethylammonio)propyl]hydroxyethylcellulose chloride manufactured by Lion Co., Ltd., trade name: Leogard MGP
(B) O-[2-hydroxy-3-(trimethylammonio)propyl] guar gum chloride manufactured by Sansho Co., Ltd., product name: Jaguar C-17
(C) Silicic anhydride Manufactured by Taki Chemical Co., Ltd., trade name: Silicic anhydride (C) Calcium carbonate, Calfine Co., Ltd., trade name: Heavy calcium carbonate (C) Calcium phosphate Manufactured by Tosoh Akzo Corporation , Product name: Dicalcium phosphate dihydrate
表3に示すように、(A)成分無配合の比較例1、(B)成分無配合の比較例3、4は、いずれも象牙細管封鎖効果(製造直後品、5サイクル後)及び象牙細管封鎖効果(保存後、5サイクル後、20サイクル後)が低く、効果の即効性及び安定性に劣った。また、(A)、(B)及び(C)成分が配合されていても(A)成分量が少ない比較例2は、象牙細管封鎖効果(保存後品、5サイクル後、20サイクル後)の低下が認められ、効果の安定性に劣っていた。
これに対して、表1、2に示すように、(A)成分を特定量以上で配合し、(B)及び(C)成分を組み合わせて配合した歯磨剤組成物(実施例)は、象牙細管封鎖効果(製造直後品、5サイクル後、20サイクル後)及び象牙細管封鎖効果(保存後品、5サイクル後、20サイクル後)が高く、効果の即効性及び安定性に優れ、また、味の良い使用感であった。更に(D)成分を配合すると、象牙細管封鎖効果がより高まり、効果の即効性及び安定性により優れていた。
As shown in Table 3, Comparative Example 1 without component (A) and Comparative Examples 3 and 4 without component (B) both have dentinal tubule sealing effect (product immediately after manufacture, after 5 cycles) and dentinal tubule sealing effect (product immediately after manufacture, after 5 cycles). The sealing effect (after storage, after 5 cycles, after 20 cycles) was low, and the immediate effect and stability were poor. In addition, even though components (A), (B), and (C) are blended, Comparative Example 2, which has a small amount of component (A), has a low dentinal tubule sealing effect (product after preservation, after 5 cycles, after 20 cycles). A decrease was observed, and the stability of the effect was poor.
On the other hand, as shown in Tables 1 and 2, a dentifrice composition (Example) containing component (A) in a specific amount or more and a combination of components (B) and (C) It has a high tubule sealing effect (immediately manufactured product, after 5 cycles, 20 cycles) and dentinal tubule sealing effect (preserved product, after 5 cycles, after 20 cycles), has excellent immediate effect and stability, and has excellent taste. It had a good usability. Furthermore, when component (D) was added, the dentinal tubule sealing effect was further enhanced, and the effect was more immediate and stable.
Claims (6)
(B)カチオン化セルロース及びカチオン化グアーガムから選ばれる1種以上のカチオン性高分子化合物
並びに
(C)シリカ、炭酸カルシウム及びリン酸カルシウムから選ばれる1種以上
を含有し、(A)成分の含有量がアルミニウムイオンとして0.13~0.70質量%であり、(B)成分の含有量が0.04~1質量%、(C)成分の含有量が3~30質量%であることを特徴とする口腔用組成物。 (A) water-soluble aluminum salt,
(B) contains one or more cationic polymer compounds selected from cationized cellulose and cationized guar gum, and (C) one or more selected from silica, calcium carbonate, and calcium phosphate, and the content of component (A) is The content of aluminum ions is 0.13 to 0.70% by mass, the content of component (B) is 0.04 to 1% by mass, and the content of component (C) is 3 to 30% by mass. Characteristic composition for oral cavity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019154241A JP7400266B2 (en) | 2019-08-27 | 2019-08-27 | Oral composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019154241A JP7400266B2 (en) | 2019-08-27 | 2019-08-27 | Oral composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021031447A JP2021031447A (en) | 2021-03-01 |
JP7400266B2 true JP7400266B2 (en) | 2023-12-19 |
Family
ID=74675374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019154241A Active JP7400266B2 (en) | 2019-08-27 | 2019-08-27 | Oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7400266B2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009149565A (en) | 2007-12-21 | 2009-07-09 | Lion Corp | Dentifrice composition |
JP2011126840A (en) | 2009-12-21 | 2011-06-30 | Lion Corp | Composition for oral cavity |
JP2014139162A (en) | 2012-12-21 | 2014-07-31 | Lion Corp | Dentifrice composition and teeth dentinal tubule blocking agent |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0742218B2 (en) * | 1983-06-17 | 1995-05-10 | ライオン株式会社 | Toothpaste composition |
JPH0742219B2 (en) * | 1984-07-26 | 1995-05-10 | ライオン株式会社 | Oral composition |
-
2019
- 2019-08-27 JP JP2019154241A patent/JP7400266B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009149565A (en) | 2007-12-21 | 2009-07-09 | Lion Corp | Dentifrice composition |
JP2011126840A (en) | 2009-12-21 | 2011-06-30 | Lion Corp | Composition for oral cavity |
JP2014139162A (en) | 2012-12-21 | 2014-07-31 | Lion Corp | Dentifrice composition and teeth dentinal tubule blocking agent |
Also Published As
Publication number | Publication date |
---|---|
JP2021031447A (en) | 2021-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5251350B2 (en) | Dentifrice composition | |
JP6610561B2 (en) | Oral composition | |
JP7173043B2 (en) | Oral stain remover, oral stain formation inhibitor, and oral composition | |
JP5397204B2 (en) | Oral composition | |
JP2020011951A (en) | Oral composition | |
WO2016121650A1 (en) | Dentifrice composition | |
JP6766823B2 (en) | Oral composition | |
JP7447470B2 (en) | dentifrice composition | |
JP2015117215A (en) | Dentifrice composition | |
JP7400266B2 (en) | Oral composition | |
JP6911845B2 (en) | Oral composition | |
JP7236623B2 (en) | oral composition | |
JP2009107988A (en) | Dentifrice composition | |
JP6409618B2 (en) | Dentifrice composition | |
JP7172028B2 (en) | oral composition | |
JP7180600B2 (en) | dentifrice composition | |
JP6753142B2 (en) | Oral composition | |
JP2010143842A (en) | Dentifrice composition | |
JP6206153B2 (en) | Dentifrice composition and dental dentinal tubule sealant | |
KR102531788B1 (en) | Oral composition and method for inhibiting discoloration thereof | |
JP7000823B2 (en) | Toothpaste composition | |
KR20220052899A (en) | oral composition | |
JP6439425B2 (en) | Liquid oral composition | |
JP6264292B2 (en) | Dentifrice composition and tooth remineralization accelerator | |
JPWO2018151076A1 (en) | Gel dentifrice composition and its stickiness inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220624 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230419 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230509 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230703 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230808 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231002 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231107 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231120 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7400266 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |